APA (7th ed.) Citation

S, Q., A, C., J, L., N, O., I, P., N, T., . . . J, M. (2023). Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity. Cell reports. Medicine, 4(12), 101341. https://doi.org/10.1016/j.xcrm.2023.101341

Chicago Style (17th ed.) Citation

S, Quesada-Vázquez, et al. "Potential Therapeutic Implications of Histidine Catabolism by the Gut Microbiota in NAFLD Patients with Morbid Obesity." Cell Reports. Medicine 4, no. 12 (2023): 101341. https://doi.org/10.1016/j.xcrm.2023.101341.

MLA (9th ed.) Citation

S, Quesada-Vázquez, et al. "Potential Therapeutic Implications of Histidine Catabolism by the Gut Microbiota in NAFLD Patients with Morbid Obesity." Cell Reports. Medicine, vol. 4, no. 12, 2023, p. 101341, https://doi.org/10.1016/j.xcrm.2023.101341.